: iStockAnalyst.com Symbols Feed

Boston Scientific’s Return To Profit Is More Bitter Than Sweet

Tue, 20 Oct 2009 19:01:46 GMT

Medical device maker Boston Scientific (BSX) reported third quarter earnings which showed the company swung back to a profit. Net income came in at $200 million or 12 cents per share after backing out one-time charges, which obviously compares favorably to the period a year ago where they lost $62 million as costs related to acquisition dragged down the results.[More...]

Boston Scientific Slumps, But Option Traders More Optimistic

Tue, 20 Oct 2009 16:47:01 GMT

Today's tickers: BSX, VMED, SPY, GME & QSFT[More...]

20 High-Quality Stocks to Fall Back On

Mon, 28 Sep 2009 21:36:35 GMT

Given the uncertainty so characteristic of autumn, consider hunkering down with the stocks in our current Wide Moat Focus Index.[More...]

Medtronic (MDT) Recalls Product

Fri, 18 Sep 2009 14:06:45 GMT

Medtronic, Inc. (MDT) is recalling some LifePak CR defibrillators as humidity may cause them to malfunction. These defibrillators were manufactured and distributed between July 9 and August 19 in 2008. The company started the process of recalling the products from July 31, 2009.[More...]

Attractive Stocks Under $35 - S&P 500 Including Bristol-Myers Squibb (BMY), Harris Corp (HRS)

Thu, 03 Sep 2009 15:41:03 GMT

Fidelity has a fund called the Low Priced Stock fund that only contains stocks with a price of below $35 a share which has been successful in the past. Following a similar strategy ValueExpectations.com has published 2 articles containing attractive stocks[More...]

Earnings Preview For Medtronic (MDT)

Mon, 24 Aug 2009 20:40:27 GMT

Medtronic, Inc. (MDT) will report its fiscal first quarter results tomorrow before the market opens. The Zacks Consensus Estimate for the current quarter is pegged at 78 cents per share. Revenues are estimated at $3.82 billion.?? ? Stability in the company’s two leading segments – heart and spinal devices – is expected in the first quarter. The company suffered major setbacks in these segments. Medtronic has lost market share of implantable cardiac defibrillators (ICDs) to rivals Boston Scientific Corp. (BSX) and St. Jude Medical (STJ) in 2009. The company also recalled roughly 37,000 pacemakers due to manufacturing defects.[More...]

St. Jude Issuing Senior Notes

Mon, 27 Jul 2009 19:13:02 GMT

St. Jude Medical, Inc. (STJ) announced that it has resorted to fund raising activities by issuing senior notes. The company has offered $700 million of senior notes due 2014 and $500 million of senior notes due 2019. The 2014 Notes have an interest of 3.750% per annum and will mature on July 15, 2014. The 2019 Notes have an interest of 4.875% per annum and will mature on July 15, 2019. ? St. Jude will use the net proceeds from these offerings primarily for repayment of its debt and repurchase of its common stock under its $500 million share repurchase program. The company has an outstanding (both short and long term) debt of roughly $1.3 billion at the end of July 4, 2009. ? St. Jude also resorted to several fund raising activities in the past few months. In December 2008, the company borrowed $500 million under its existing[More...]

St. Jude Medical fails to cheer the market - Analyst Blog

Thu, 23 Jul 2009 13:26:33 GMT

St. Jude Medical, Inc. (STJ)">STJ), a leading medical device manufacturer that designs, manufactures and distributes medical devices to treat cardiovascular and neurological conditions, reported financial results for the second quarter of 2009. EPS was $0.63, an increase of 15% y/y and in line with the street estimates. However, the company’s share fell roughly 9% at the close of the trading yesterday on concerns regarding weakness in the company’s largest revenue generating segment, cardiac rhythm management.? Net sales in the quarter were $1,184 million, an increase of 4% y/y. The company met with foreign currency (FX) headwinds in the quarter. Excluding FX, net sales increased 10% y/y. Net sales in terms of business segments were as follows:? Cardiac Rhythm Management[More...]

Boston Scientific Beats Street

Tue, 21 Jul 2009 16:10:29 GMT

Boston Scientific Q2 results beat Street expectations Boston Scientific Corporation (BSX), a leading manufacturer of medical devices and products used in a broad range of interventional medical specialties, reported a strong second quarter of fiscal 2009 results. Excluding special items, adjusted EPS was $0.20, same as that in the year-ago quarter but ahead of Street expectations of $0.14. ? Quarterly results Net Sales Net sales for the quarter were $2,074 million, an increase of 2% y/y. Excluding the unfavorable impact of foreign exchange (FX), net sales increased 7% y/y. Growth was seen across all the major business segments as depicted below: In[More...]

Midnight Trader's Pre Market Report for July 16, 2009

Thu, 16 Jul 2009 13:25:00 GMT

Technology shares are lower in the pre-market session. Nokia (NOK) Q2 sales fell to 9.9 bln euros from 13.1 bln euros. EPS fell to 0.15 euros from 0.37 euros. Nokia said its mobile device volumes were 103.2 million units, down 15% year on year and up 11%[More...]

MGM Mirage, Caterpillar, Apple are big movers

Tue, 20 Oct 2009 21:46:00 GMT

NEW YORK - The following stocks were among those that moved substantially or traded heavily Tuesday on the New York Stock Exchange:
The medical device maker forecast disappointing earnings on slower sales of its implants, prompting an analyst to downgrade its stock.
The companys thid-quarter profit dropped 53 percent as dealers continue to chip away at stockpiles rather than placing new orders.

: iStockAnalyst.com Symbols Feed

Boston Scientific’s Return To Profit Is More Bitter Than Sweet

Boston Scientific Slumps, But Option Traders More Optimistic

20 High-Quality Stocks to Fall Back On

Medtronic (MDT) Recalls Product

Attractive Stocks Under $35 - S&P 500 Including Bristol-Myers Squibb (BMY), Harris Corp (HRS)

Earnings Preview For Medtronic (MDT)

St. Jude Issuing Senior Notes

St. Jude Medical fails to cheer the market - Analyst Blog

Boston Scientific Beats Street

Midnight Trader's Pre Market Report for July 16, 2009

MGM Mirage, Caterpillar, Apple are big movers

Boston Scientific returns to profit in 3rd qtr

BosSci Paying $716M to J&J: Action Resolves Some, but Not All, Heart Stent Suits

Paulson fund buys 168M shares of Bank of America

Angiotech Pharmaceuticals, Inc. Announces Financial Results for the Second Quarter Ended June 30, 2009

Medtronic Resolves Heart Stent Patent Disputes: Pact Specifies $400M Payment to Abbott Labs, No Lawsuits for 10 Years

Boston Scientific Q2 Net Income Increases

Stocks open higher on reports CIT close to rescue

Medtronic raises CEO pay 26 percent to $8.9M

Elk Run Investor Raising $1 Billion: Steve Burrill is Creating a Unique Fund to Back Bioscience Center Near Rochester.

Myriad Genetics Elects Louise Phanstiel and Lawrence Best to Its Board of Directors

GHX Working With Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance With GLN Sunrise Date ; GHX Assisting With Pilots, Transaction Guides, User Groups and Development of Services

Boston Scientific Announces Schedule for European Society of Cardiology Congress

Boston Scientific to Webcast Conference Call Discussing Results of Landmark MADIT-CRT Trial

BenchmarkJournal.Com Free Analyst Review for HNZ, BMO, CTB, BSX, XRAY and YHOO

Ahead of the Bell: Sunwin International Neutraceuticals - August 19, 2009

Trimedyne Reports Its Financial Results for the Quarter and Nine Months Ended June 30, 2009

Angiotech Pharmaceuticals, Inc. Announces Financial Results for the Second Quarter Ended June 30, 2009

Boston Scientific to Participate in BMO Capital Markets Health Care Conference

Stock in Focus: Sunwin International Neutraceuticals - July 30, 2009

Form 4 BOSTON SCIENTIFIC CORP For: Nov 02 Filed by: Pucel Kenneth (10K)

Form 4 BOSTON SCIENTIFIC CORP For: Nov 02 Filed by: NICHOLAS PETER M (10K)

Form 4 BOSTON SCIENTIFIC CORP For: Nov 02 Filed by: Kucheman William (10K)

Form 4 ABELE JOHN E For: Nov 02 (10K)

Form 4 ABELE JOHN E For: Oct 29 (10K)

Form 4 BOSTON SCIENTIFIC CORP For: Oct 28 Filed by: NICHOLAS PETER M (10K)

Form 4 ABELE JOHN E For: Oct 28 (10K)

Form 4 BOSTON SCIENTIFIC CORP For: Oct 27 Filed by: ABELE JOHN E (10K)

Form 4 BOSTON SCIENTIFIC CORP For: Oct 23 Filed by: ABELE JOHN E (10K)

Form 4 BOSTON SCIENTIFIC CORP For: Oct 22 Filed by: ABELE JOHN E (10K)